OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhalable CAR-T cell-derived exosomes as paclitaxel carriers for treating lung cancer
Wei Zheng, Tianchuan Zhu, Lantian Tang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 39

Showing 26-50 of 39 citing articles:

CAR T Cells in Lung Cancer: Targeting Tumor-Associated Antigens to Revolutionize Immunotherapy
Sattam Khulaif Alenezi
Pathology - Research and Practice (2025), pp. 155947-155947
Closed Access

Novel therapeutic approaches for non-small cell lung cancer: an updated view
Niloufar Orooji, Shabnam Babaei, Manouchehr Fadaee, et al.
Journal of drug targeting (2025), pp. 1-29
Closed Access

Exosomes of immune cell origin and their therapeutic potential for tumors
Hongru Ai, Yitan Zou, Xinya Zheng, et al.
View (2024)
Open Access | Times Cited: 4

Tumor Microenvironment-Derived Exosomes: A Double-Edged Sword for Advanced T Cell-Based Immunotherapy
Ye Lu, Jiarong Zheng, Pei Lin, et al.
ACS Nano (2024)
Closed Access | Times Cited: 4

The latest applications of exosome-mediated drug delivery in anticancer therapies
Zhiwei Wen, Wei Zhang, Wei Wu
Colloids and Surfaces B Biointerfaces (2025) Vol. 249, pp. 114500-114500
Closed Access

Cancer chemoprevention: signaling pathways and strategic approaches
Junling Ren, Guangli Yan, Le Yang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access

Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: A comprehensive review
Chaozhi Tang, Yuling Zhang
Pathology - Research and Practice (2024) Vol. 262, pp. 155518-155518
Closed Access | Times Cited: 3

Focusing on exosomes to overcome the existing bottlenecks of CAR-T cell therapy
Siheng Zhang, Linglong Peng, Yifei Chen, et al.
Inflammation and Regeneration (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 3

Advancements in Micellar Formulation: Drug Delivery Vehicle for Water-Insoluble Drugs
Lokesh Sharma, Divya S. Khurana, Preeti Patel, et al.
Recent Advances in Drug Delivery and Formulation (2024) Vol. 18, Iss. 3, pp. 188-207
Closed Access | Times Cited: 2

Advances in Pulmonary Protein Delivery Systems
Yuanyuan Zhao, Shuai Liu, Xueguang Lu
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 5
Open Access | Times Cited: 1

Unraveling the Connection: Extracellular Vesicles and Non-Small Cell Lung Cancer
Jiankang Wu, Yan Chen
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 8139-8157
Open Access | Times Cited: 1

Exploring the potential of the convergence between extracellular vesicles and CAR technology as a novel immunotherapy approach
O. Bar, Angel Porgador, Tomer Cooks
Journal of Extracellular Biology (2024) Vol. 3, Iss. 9
Open Access | Times Cited: 1

Engineered extracellular vesicles for cancer drug delivery and therapeutics
Marina Pérez-Capó, Antònia Obrador‐Hevia, Diego Pérez, et al.
Current Opinion in Physiology (2024) Vol. 39, pp. 100755-100755
Closed Access

Exosomes as novel nanocarriers for cancer therapy
Jueyu Li, Jinhui Zan, Zhi‐Xiang Xu, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 101, pp. 106262-106262
Closed Access

Previous Page - Page 2

Scroll to top